Michael Crowley
CIK 1629381 · View on SEC EDGAR ↗
Insider
First SEC filing: Dec. 31, 2014 · Latest: Sept. 13, 2016
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 76 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
76 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 14, 2025 | BIO | S | 3,000 | $247.06 | $741,180 | 8,171 Direct | -26.86% | Disposed | 47.0% (price as of 2026-08-19) |
| June 13, 2024 | BIO | S | 369 | $281.91 | $104,025 | 6,573 Direct | -5.32% | Disposed | 28.8% (price as of 2026-08-19) |
| Feb. 27, 2024 | BIO | S | 3,000 | $336.00 | $1,008,000 | 6,942 Direct | -30.18% | Disposed | 8.1% (price as of 2026-08-19) |
| Nov. 28, 2023 | BIO | S | 642 | $305.10 | $195,874 | 6,942 Direct | -8.47% | Disposed | 19.1% (price as of 2026-08-19) |
| June 15, 2023 | BIO | S | 500 | $379.39 | $189,695 | 6,040 Direct | -7.65% | Disposed | -4.3% (price as of 2026-08-19) |
| Aug. 9, 2021 | BIO | S | 430 | $755.72 | $324,960 | 3,669 Direct | -10.49% | Disposed | -51.9% (price as of 2026-08-19) |
| Aug. 9, 2021 | BIO | S | 2,570 | $754.80 | $1,939,836 | 4,099 Direct | -38.54% | Disposed | -51.9% (price as of 2026-08-19) |
| Dec. 15, 2020 | BIO | S | 374 | $580.67 | $217,171 | 3,669 Direct | -9.25% | Disposed | -37.4% (price as of 2026-08-19) |
| Aug. 14, 2019 | BIO | S | 325 | $320.00 | $104,000 | 3,100 Direct | -9.49% | Disposed | 13.5% (price as of 2026-08-19) |
| Dec. 14, 2018 | BIO | S | 392 | $248.03 | $97,228 | 3,425 Direct | -10.27% | Disposed | 46.4% (price as of 2026-08-19) |
| June 13, 2018 | BIO | S | 350 | $303.42 | $106,197 | 2,142 Direct | -14.04% | Disposed | 19.7% (price as of 2026-08-19) |
| Dec. 4, 2017 | BIO | S | 1,000 | $258.39 | $258,390 | 2,492 Direct | -28.64% | Disposed | 40.6% (price as of 2026-08-19) |
| Aug. 11, 2017 | BIO | S | 700 | $215.91 | $151,137 | 2,060 Direct | -25.36% | Disposed | 68.2% (price as of 2026-08-19) |
| Sept. 10, 2016 | BIO | S | 523 | $155.02 | $81,075 | 2,710 | — | — | 134.3% (price as of 2026-08-19) |
| Aug. 18, 2016 | BIO | S | 669 | $153.00 | $102,357 | 1,868 Direct | -26.37% | Disposed | 137.4% (price as of 2026-08-19) |
| Nov. 13, 2015 | BIO | S | 549 | $136.16 | $74,752 | 2,537 Direct | -17.79% | Disposed | 166.8% (price as of 2026-08-19) |
| March 10, 2015 | BIO | S | 200 | $134.05 | $26,810 | 2,112 Direct | -8.65% | Disposed | 171.0% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 14, 2025 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,000) | $159.32 | Sept. 7, 2026 | 3,000 | Disposed |
| Sept. 6, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (3,456) | — | — | 3,456 | Acquired |
| Sept. 3, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (557) | — | — | 557 | Disposed |
| Sept. 2, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (434) | — | — | 434 | Disposed |
| Sept. 1, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (405) | — | — | 405 | Disposed |
| Sept. 1, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (520) | — | — | 520 | Disposed |
| Sept. 1, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (751) | — | — | 751 | Disposed |
| March 8, 2024 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,535) | $343.76 | March 8, 2034 | 3,535 | Acquired |
| Feb. 27, 2024 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,000) | $215.98 | Sept. 5, 2027 | 3,000 | Disposed |
| Sept. 4, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 3, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (557) | — | — | 557 | Disposed |
| Sept. 2, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (433) | — | — | 433 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (405) | — | — | 405 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (520) | — | — | 520 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (3,005) | — | — | 3,005 | Acquired |
| Sept. 5, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 4, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 3, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (557) | — | — | 557 | Disposed |
| Sept. 2, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (433) | — | — | 433 | Disposed |
| Sept. 1, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (405) | — | — | 405 | Disposed |
| Sept. 1, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2,082) | — | — | 2,082 | Acquired |
| Sept. 7, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 5, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 4, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 3, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (557) | — | — | 557 | Disposed |
| Sept. 2, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (433) | — | — | 433 | Disposed |
| Sept. 1, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (1,621) | $814.95 | Sept. 1, 2031 | 1,621 | Acquired |
| Sept. 1, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1,621) | — | — | 1,621 | Acquired |
| Aug. 9, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,000) | $139.56 | Sept. 11, 2025 | 3,000 | Disposed |
| Sept. 3, 2020 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (556) | — | — | 556 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 31, 2014 | BIO | Bio-Rad A Common Stock | 2,312 | Direct |
| Dec. 31, 2014 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (250) | 250 | Direct |
| Dec. 31, 2014 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (462) | 462 | Direct |
| Dec. 31, 2014 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (1,002) | 1,002 | Direct |
| Dec. 31, 2014 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (1,504) | 1,504 | Direct |
| Dec. 31, 2014 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (1,945) | 1,945 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $441,663 | — | $928,019 | $235,208 | $203,229 | — | $18,174 | $1,826,292 |
| 2016 | $388,074 | — | — | — | — | — | — | $1,167,120 |
| 2015 | $441,586 | — | — | — | $267,128 | — | $215,613 | $1,448,155 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.